Pfizer

Pfizer takes Vyndaqel copay fight to Supreme Court, decrying 'staggeringly overbroad' anti-kickback rule
Fierce Pharma
Mon, 10/17/22 - 11:31 pm
Pfizer
Supreme Court
kickbakcs
tafamidis
copays
Vyndaqel
FDA Review: Phanes, Pfizer, GSK and More
BioSpace
Fri, 10/14/22 - 10:38 am
FDA
Phanes
Pfizer
GSK
Regeneron
Eagle Pharmaceuticals
Galactin Therapeutics
BridgeBio
Gilead Sciences
Covis Pharma
scPharmaceuticals
XACT Robotics
BioMind Labs
Few safe havens surface in another down quarter for biopharma
EP Vantage
Fri, 10/14/22 - 10:03 am
biopharma stocks
COVID-19
Eli Lilly
Bristol Myers Squibb
Merck
Daiichi Sankyo
Vertex Pharmaceuticals
Takeda
Neurocrine
Sarepta Therapeutics
Orion
Pfizer
GSK
Roche
Moderna Therapeutics
BeiGene
BioNTech
Novavax
CureVac
GSK hits back in high-stakes RSV vaccine game, posting phase 3 data that suggest it has edge on Pfizer
Fierce Biotech
Thu, 10/13/22 - 09:47 am
GSK
RSV
vaccines
clinical trials
Pfizer
JNJ
Moderna Therapeutics
RSVPreF3
Pfizer and BioNTech Announce Positive Early Data From Clinical Trial of Omicron BA.4/BA.5-Adapted Bivalent Booster in Individuals 18 Years and Older
Yahoo/Businesswire
Thu, 10/13/22 - 09:26 am
Pfizer
BioNTech
clinical trials
COVID-19
vaccines
boosters
bivalent boosters
FDA authorizes Moderna and Pfizer-BioNTech Bivalent COVID vaccines for booster doses in younger age groups
Pharma Live
Wed, 10/12/22 - 10:36 am
FDA
Pfizer
Moderna Therapeutics
BioNTech
vaccines
boosters
bivalent boosters
COVID-19
pediatric
FWIW, Pfizer exec denies company negotiated vaccine deal with Europe via text messages
Fierce Pharma
Tue, 10/11/22 - 04:14 pm
Pfizer
Pharma CEOs
Albert Bourla
vaccines
COVID-19
Europe
After selling startups to Novo and Pfizer, Andera raises record €456M for latest life sciences fund
Fierce Biotech
Mon, 10/10/22 - 10:30 am
Andera Partners
funding
life sciences
startups
Pfizer
Novo Nordisk
Europe
venture capital
From Africa to Australia and beyond, BioNTech's global mRNA ambitions take flight
Fierce Pharma
Fri, 10/7/22 - 10:49 am
Pfizer
BioNTech
MRNA
Australia
COVID-19
Pfizer’s dealmaking continues as GBT, Biohaven acquisitions close
Medical Marketing and Media
Wed, 10/5/22 - 10:43 am
Pfizer
M&A
Global Blood Therapeutics
Biohaven
No big bang for biopharma buyouts
EP Vantage
Wed, 10/5/22 - 10:29 am
M&A
Pfizer
Global Blood Therapeutics
Amgen
ChemoCentryx
Novo Nordisk
Forma
Alcon
Aerie Pharmaceuticals
Gilead Sciences
MiroBio
With Pfizer sale in the rearview, Biohaven veers toward Kv7 platform following late-stage trial fails, delays
Fierce Biotech
Tue, 10/4/22 - 11:45 pm
Pfizer
Biohaven
migraines
epilepsy
Pfizer’s PARP inhibitor combo treatment passes primary endpoint — but details are slim
Endpoints
Tue, 10/4/22 - 11:06 am
Pfizer
Xtandi
Talzenna
PARP inhibitors
Medivation
clinical trials
prostate cancer
Pfizer pulls trigger on Voyager gene therapy capsid deal, clearing it to fire TRACER at CNS disease
Fierce Biotech
Tue, 10/4/22 - 10:48 am
Pfizer
Voyager Therapeutics
capsids
gene therapy
Alnylam's new Onpattro data raise fresh doubts in heart disease fight against Pfizer: analyst
Fierce Pharma
Mon, 10/3/22 - 11:41 pm
Alnylam
Onpattro
Pfizer
ATTR-CM
Amid scrutiny around Europe's vaccine purchase, Pfizer CEO Albert Bourla pulls out of committee hearing
Fierce Pharma
Mon, 10/3/22 - 11:39 pm
Pfizer
Albert Bourla
Pharma CEOs
COVID-19
Europe
vaccines
Real-time reviews for cell and gene therapies? Pfizer to FDA: Yes, please
Endpoints
Wed, 09/28/22 - 10:32 pm
FDA
Pfizer
cancer
RTOR
oncology
Pfizer/BioNTech seek FDA nod for new COVID boosters for children
Yahoo/Reuters
Mon, 09/26/22 - 10:39 am
Pfizer
BioNTech
COVID-19
FDA
vaccines
pediatric
boosters
Pfizer whittles down US donation deal as global COVID-19 vaccine demand slumps
Fierce Pharma
Sun, 09/25/22 - 02:11 pm
Pfizer
vaccines
COVID-19
Months after exiting clinical hold, Pfizer readies to resume dosing in phase 3 gene therapy trial
Fierce Biotech
Fri, 09/23/22 - 10:50 am
Pfizer
clinical trials
hemophilia A
gene therapy
FDA
giroctocogene fitelparvovec

Pages